Risk of MI according to presence of Kozak C allele: analysis stratified by cardiovascular risk factors
Risk factor . | MI cases (n = 78) . | Controls (n = 384) . | OR4-150 . | (95% CI)4-150 . | P value for interaction . | ||
---|---|---|---|---|---|---|---|
T/C or C/C . | T/T . | T/C or C/C . | T/T . | ||||
Overall | 11 | 67 | 91 | 293 | 0.53 | (0.27-1.05) | |
Current smoking | |||||||
No | 4 | 20 | 74 | 231 | 0.62 | (0.21-1.88) | 0.88 |
Yes | 7 | 47 | 17 | 62 | 0.55 | (0.21-1.46) | |
Obesity | |||||||
BMI < 27.3 kg/m2 | 2 | 32 | 66 | 213 | 0.20 | (0.05-0.87) | 0.09 |
BMI ≥ 27.3 kg/m2 | 9 | 35 | 25 | 77 | 0.81 | (0.33-1.94) | |
Hypertension, diabetes, or hypercholesterolemia | |||||||
No | 2 | 28 | 70 | 218 | 0.22 | (0.05-0.96) | 0.10 |
Yes | 9 | 39 | 21 | 75 | 0.83 | (0.35-1.99) | |
Early family history of MI in first degree relative | |||||||
No | 7 | 43 | 75 | 249 | 0.55 | (0.24-1.26) | 0.88 |
Yes | 4 | 22 | 14 | 39 | 0.43 | (0.11-1.62) | |
Plasma homocysteine | |||||||
<12.6 mg/dL | 4 | 34 | 70 | 216 | 0.36 | (0.12-1.05) | 0.21 |
≥12.6 mg/dL | 7 | 33 | 19 | 74 | 0.92 | (0.34-2.48) | |
Factor V or prothrombin mutations | |||||||
No | 10 | 56 | 88 | 272 | 0.55 | (0.27-1.13) | 0.93 |
Yes | 1 | 11 | 3 | 18 | 0.61 | (0.05-6.88) | |
HPA-2b allele | |||||||
No | 57 | 10 | 242 | 79 | 0.54 | (0.26-1.10) | 0.87 |
Yes | 1 | 10 | 12 | 51 | 0.45 | (0.05-3.89) |
Risk factor . | MI cases (n = 78) . | Controls (n = 384) . | OR4-150 . | (95% CI)4-150 . | P value for interaction . | ||
---|---|---|---|---|---|---|---|
T/C or C/C . | T/T . | T/C or C/C . | T/T . | ||||
Overall | 11 | 67 | 91 | 293 | 0.53 | (0.27-1.05) | |
Current smoking | |||||||
No | 4 | 20 | 74 | 231 | 0.62 | (0.21-1.88) | 0.88 |
Yes | 7 | 47 | 17 | 62 | 0.55 | (0.21-1.46) | |
Obesity | |||||||
BMI < 27.3 kg/m2 | 2 | 32 | 66 | 213 | 0.20 | (0.05-0.87) | 0.09 |
BMI ≥ 27.3 kg/m2 | 9 | 35 | 25 | 77 | 0.81 | (0.33-1.94) | |
Hypertension, diabetes, or hypercholesterolemia | |||||||
No | 2 | 28 | 70 | 218 | 0.22 | (0.05-0.96) | 0.10 |
Yes | 9 | 39 | 21 | 75 | 0.83 | (0.35-1.99) | |
Early family history of MI in first degree relative | |||||||
No | 7 | 43 | 75 | 249 | 0.55 | (0.24-1.26) | 0.88 |
Yes | 4 | 22 | 14 | 39 | 0.43 | (0.11-1.62) | |
Plasma homocysteine | |||||||
<12.6 mg/dL | 4 | 34 | 70 | 216 | 0.36 | (0.12-1.05) | 0.21 |
≥12.6 mg/dL | 7 | 33 | 19 | 74 | 0.92 | (0.34-2.48) | |
Factor V or prothrombin mutations | |||||||
No | 10 | 56 | 88 | 272 | 0.55 | (0.27-1.13) | 0.93 |
Yes | 1 | 11 | 3 | 18 | 0.61 | (0.05-6.88) | |
HPA-2b allele | |||||||
No | 57 | 10 | 242 | 79 | 0.54 | (0.26-1.10) | 0.87 |
Yes | 1 | 10 | 12 | 51 | 0.45 | (0.05-3.89) |
MI indicates myocardial infarction; OR, odds ratio; CI, confidence interval; BMI, body mass index.
OR and 95% CI calculated for presence of C allele (homozygous or heterozygous) compared with TT genotype, and adjusted for age.